Lanean...
Rethinking interleukin-6 blockade for treatment of COVID-19
Interleukin-6 (IL-6) is a pleiotropic cytokine with effects in immune regulation, inflammation, and infection. The use of drugs that inhibit IL-6 biological activity has been proposed as a treatment for patients with Coronavirus Disease 2019 (COVID-19). The rationale for this approach includes commi...
Gorde:
| Argitaratua izan da: | Med Hypotheses |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
The Authors. Published by Elsevier Ltd.
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7320867/ https://ncbi.nlm.nih.gov/pubmed/32758889 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2020.110053 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|